COVID-19 Exposure and Family Impact Scales for Adolescents and Young Adults
|
April 23, 2022
|
PC3I Authors Lisa A. Schwartz |
Journal of Pediatric Psychology
|
Modifiable risk factors associated with long-term survival in women with serous ovarian cancer: a National Cancer Database study
|
April 23, 2022
|
PC3I Authors Anna Jo Smith |
International Journal of Gynecological Cancer
|
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer
|
April 22, 2022
|
PC3I Authors Charu Aggarwal |
Journal of Clinical Oncology
|
Perspectives of State Association Leaders During the COVID-19 Pandemic
|
April 20, 2022
|
PC3I Authors George Demiris |
American Journal of Hospice and Palliative Care
|
How Referring Providers Choose Specialists for Their Patients: a Systematic Review
|
April 20, 2022
|
PC3I Authors Shivan Mehta |
Journal of General Internal Medicine
|
Policies and Practices to Address Cancer’s Long-Term Adverse Consequences
|
April 19, 2022
|
PC3I Authors Larry Shulman |
Journal of the National Cancer Institute
|
Racial and Ethnic Disparities in Surgical Outcomes after Postmastectomy Breast Reconstruction
|
April 15, 2022
|
PC3I Authors Oluwadamilola "Lola" Fayanju |
Journal of the American College of Surgeons
|
Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer
|
April 14, 2022
|
PC3I Authors Larry Shulman |
Breast Cancer Research and Treatment
|
Cancer-related inflammation and depressive symptoms: Systematic review and meta-analysis
|
April 13, 2022
|
PC3I Authors Meredith Doherty |
Cancer
|
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial
|
April 13, 2022
|
PC3I Authors Charu Aggarwal |
Journal for Immunotherapy of Cancer
|
Oncology alternative payment models: lessons from commercial insurance
|
April 11, 2022
|
PC3I Authors |
AJMC
|
A Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis
|
April 8, 2022
|
PC3I Authors Anil Vachani |
JMIR Formative Research
|
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed
|
April 8, 2022
|
PC3I Authors Charu Aggarwal; Melina Marmarelis; Christopher A. D’Avella |
Clinical Lung Cancer
|
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study
|
April 8, 2022
|
PC3I Authors Charu Aggarwal; Melina Marmarelis; Christopher A. D’Avella; Anil Vachani |
JTO Clinical and Research Reports
|
Intensity of end-of-life care for gynecologic cancer patients by primary oncologist specialty
|
April 5, 2022
|
PC3I Authors Emily Ko |
International Journal of Gynecological Cancer
|
Oncologist Peer Comparisons as a Behavioral Science Strategy to Improve Hospice Utilization
|
April 4, 2022
|
PC3I Authors Ramy Sedhom; Larry Shulman |
JCO Oncology Practice
|
Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana
|
April 3, 2022
|
PC3I Authors Surbhi Grover |
BMC Women's Health
|
Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement
|
March 31, 2022
|
PC3I Authors Larry Shulman |
The Lancet. Oncology
|
An Assistive Electronic Patient-Reported Outcome Monitoring Intervention for Management of Immune-Related Toxic Effects-Moving Toward Efficiency and Scale
|
March 31, 2022
|
PC3I Authors Samuel Takvorian |
JAMA Network Open
|
Photodynamic therapy for stage I and II non-small cell lung cancer: A SEER-Medicare analysis 2000-2016
|
March 31, 2022
|
PC3I Authors Anil Vachani |
Medicine (Baltimore)
|